Two anti-inflammatory compounds shown to be capable of accelerating recovery from COVID-19
Monoclonal antibody and experimental drug given to patients promoted rapid improvement of respiratory function in patients in severe condition
17-Nov-2020 -
Two independent clinical studies – one by researchers at the Center for Cell-Based Therapy (CTC) in Ribeirão Preto, state of São Paulo (Brazil), on the monoclonal antibody eculizumab, and the other by scientists at the University of Pennsylvania in Philadelphia (USA) on an experimental drug ...
Covid-19
eculizumab
monoclonal antibodies